Driving with Type 1 Diabetes: Real-World Evidence to Support Starting Glucose Level and Frequency of Monitoring During Journeys

There is limited evidence supporting the recommendation that drivers with insulin-treated diabetes need to start journeys with glucose >90 mg/dL. Glucose levels of drivers with type 1 diabetes were monitored for 3 weeks using masked continuous glucose monitoring (CGM). Eighteen drivers (median [I...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes technology & therapeutics 2022-05, Vol.24 (5), p.350-356
Hauptverfasser:	Trawley, Steven, Stephens, Amanda N, McAuley, Sybil A, Speight, Jane, Hendrieckx, Christel, Vogrin, Sara, Lee, Melissa H, Paldus, Barbora, Bach, Leon A, Burt, Morton G, Cohen, Neale D, Colman, Peter G, Davis, Elizabeth A, Holmes-Walker, D Jane, Jenkins, Alicia J, Kaye, Joey, Keech, Anthony C, Kumareswaran, Kavita, MacIsaac, Richard J, McCallum, Roland W, Sims, Catriona M, Stranks, Stephen N, Sundararajan, Vijaya, Ward, Glenn M, Jones, Timothy W, O'Neal, David N
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Automobile driving Blood Glucose Blood Glucose Self-Monitoring Diabetes Diabetes Mellitus, Type 1 - drug therapy Glucose Glucose monitoring Humans Hypoglycemia Hypoglycemia - drug therapy Hypoglycemia - prevention & control Hypoglycemic Agents - therapeutic use Insulin - therapeutic use Male Traffic accidents & safety Travel
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!